{"nctId":"NCT01601977","briefTitle":"Validation of the AVAPS AE Algorithm in Chronic Obstructive Pulmonary Disease (COPD) Patients","startDateStruct":{"date":"2012-05"},"conditions":["COPD","OSA"],"count":10,"armGroups":[{"label":"Intervention","type":"EXPERIMENTAL","interventionNames":["Device: AVAPS-AE"]},{"label":"Usual care","type":"ACTIVE_COMPARATOR","interventionNames":["Device: Usual care"]}],"interventions":[{"name":"AVAPS-AE","otherNames":[]},{"name":"Usual care","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age â‰¥ 21\n* Diagnosis of COPD\n* Currently using Bilevel device for COPD-OSA overlap syndrome\n* Ability to provide consent\n* Documentation of medical stability by PI\n\nExclusion Criteria:\n\n* Subjects, who are acutely ill, medically complicated or who are medically unstable.\n* Subjects in whom PAP therapy is otherwise medically contraindicated.\n* Subjects who have had surgery of the upper airway, nose, sinus, or middle ear within the previous 90 days.\n* Subjects with untreated, non-OSA sleep disorders, including but not limited to; insomnia, periodic limb movement syndrome, or restless legs syndrome (PLMI \\> 10).","healthyVolunteers":false,"sex":"ALL","minimumAge":"21 Years","maximumAge":"90 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Control of Nocturnal Hypoventilation","description":"transcutaneous CO2 recording from overnight sleep study whilst using the device at 6 weeks compared to baseline control when using usual device","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.5","spread":"1.6"},{"groupId":"OG001","value":"6.7","spread":"1.4"}]}]}]},{"type":"SECONDARY","title":"Health Related Quality of Life","description":"Severe Respiratory Insufficiency (SRI) questionnaire. Higher scores indicate better quality of life (minimum 0, maximum 100)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"60","spread":"15"},{"groupId":"OG001","value":"59","spread":"16"}]}]}]},{"type":"SECONDARY","title":"Health Related Quality of Life","description":"Severe Respiratory Insufficiency (SRI) questionnaire. Higher scores indicate better quality of life (minimum 0, maximum 100)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"61","spread":"17"},{"groupId":"OG001","value":"59","spread":"16"}]}]}]},{"type":"SECONDARY","title":"Total Sleep Time","description":"Full polysomnography performed at baseline (usual device) and 6 weeks (trial device) to examine TST","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"330","spread":"72"},{"groupId":"OG001","value":"306","spread":"72"}]}]}]},{"type":"SECONDARY","title":"Control of Nocturnal Hypoventilation","description":"mean tcCO2","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.4","spread":"1.7"},{"groupId":"OG001","value":"6.5","spread":"1.4"}]}]}]},{"type":"SECONDARY","title":"Exercise Capacity","description":"6 minute walk test","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"190","spread":"63"},{"groupId":"OG001","value":"175","spread":"72"}]}]}]},{"type":"SECONDARY","title":"Exacerbation Frequency","description":"patient reported exacerbations following 6 weeks of device usage","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":10},"commonTop":[]}}}